loading ...
Medicine & Health / Medications news 1234

FDA OKs Amitiza for treatment of IBS-C

April 30, 2008 | User rating: not rated yet | No comments yet

The U.S. Food and Drug Administration announced approval of Amitiza (lubiprostone) to treat constipation associated with irritable bowel syndrome.


FDA rejects Singulair-Claritin combination

April 30, 2008 | User rating: not shown ( 2 vote(s) ) | No comments yet

The U.S. Food and Drug Administration rejected a proposed pill that would combine the drugs Claritin and Singular, Schering-Plough said.


FDA OKs Relistor for opioid patients

April 28, 2008 | User rating: not shown ( 2 vote(s) ) | No comments yet

The U.S. Food and Drug Administration has approved Relistor (methylnaltrexone bromide) to help restore bowel function in patients receiving opioids.


Baxter may stay out of Heparin business

April 25, 2008 | User rating: not rated yet | No comments yet

The head of Baxter International Inc. said the company has not decided whether it will resume selling the blood thinner heparin in the United States.


New adult ADHD drug receives FDA approval

April 24, 2008 | User rating: not shown ( 2 vote(s) ) | No comments yet

The U.S. Food and Drug Administration has approved the first prodrug designed for once-daily treatment of adults with ADHD.


Industrial chemical found in Cubicin

April 10, 2008 | User rating: not rated yet | No comments yet

The U.S. Food and Drug Administration said Cubist Pharmaceuticals is warning that an industrial chemical has been found in the antibiotic Cubicin.


Drug poisoning growing cause of death

April 04, 2008 | User rating: not shown ( 3 vote(s) ) | No comments yet

A government report said poisoning is the second-leading cause of injury death in the United States after motor vehicle accidents.


FDA reviews diabetic and HIV medications

March 27, 2008 | User rating: not rated yet | No comments yet

The U.S. Food and Drug Administration has announced safety reviews of the FDA-approved medications Regranex Gel, Ziagen and Videx.


Scientists test new prostate disease drug

March 27, 2008 | User rating: not shown ( 4 vote(s) ) | No comments yet

A Canadian-headquartered biopharmaceutical company is conducting the second Phase 3 study of a new drug designed to treat prostate disease.


Heparin recall spreads in Europe

March 27, 2008 | User rating: not shown ( 1 vote(s) ) | No comments yet

France, Italy and Denmark are recalling heparin after an Italian firm purchased contaminated ingredients from China, EU drug regulators said.


FDA OKs new adhesive to treat burn victims

March 20, 2008 | User rating: not rated yet | No comments yet

The U.S. Food and Drug Administration approved a medical adhesive -- a fibrin sealant called Artiss -- for use in attaching skin grafts to burn patients.


Doctors boosting marijuana dosages

March 19, 2008 | User rating: 4.3 / 5 after 6 vote(s) | No comments yet

Canadian health officials say doctors are increasing the dosages of medical marijuana they prescribe for patients.


New form of aspirin is easier on stomachs

March 18, 2008 | User rating: 4.2 / 5 after 5 vote(s) | No comments yet

Italian researchers have altered the atomic makeup of aspirin to make it less harsh on users' stomach linings, experts said.


FDA to test all heparin at U.S. border

March 16, 2008 | User rating: not rated yet | No comments yet

The U.S. Food and Drug Administration has issued an import alert and plans to test all shipments of the drug heparin before they enter the country.


Anemia drugs under scrutiny

March 13, 2008 | User rating: not shown ( 1 vote(s) ) | No comments yet

U.S. drug regulators are contemplating further restrictions on the use of drugs to combat anemia in cancer patients.


Pages: 1 Next »